“…Genetic testing has proved to be a cost‐effective way to diagnose conditions and direct medical resources toward appropriate therapies, surveillance, or treatment, though many barriers and limitations remain implementation of such testing (Muth et al., 2019 ; O'Brien et al., 2021 ; Serrano et al., 2023 ). The COVID‐19 pandemic both exposed these access disparities and eased some barriers by increasing the uptake of telemedicine in genetics clinics, willingness to share genetic information, and to undergoing genetic testing (Deruelle et al., 2023 ; Macalino et al., 2023 ). However, some challenges were exacerbated such as the exclusion of patients without reliable access to the internet or technological literacy to utilize telemedicine (Mann et al., 2021 ).…”